Cargando…
Predicting cancer drivers: are we there yet?
Genomic variants with a key role in causing cancer or affecting the response to cancer therapeutics need to be identified so that they can be targeted for therapy. The transFIC tool aims to identify somatic point mutations that drive cancer in sequencing projects. This package is available as a web...
Autores principales: | Krishnan, Vidhya G, Ng, Pauline C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580422/ https://www.ncbi.nlm.nih.gov/pubmed/23181697 http://dx.doi.org/10.1186/gm389 |
Ejemplares similares
-
Cultivating Yet-to-be Cultivated Microbes: The Challenge Continues
por: Narihiro, Takashi, et al.
Publicado: (2013) -
Prostate cancer screening: and yet it moves!
por: Kwiatkowski, Maciej, et al.
Publicado: (2015) -
Novel cancer drivers: mining the kinome
por: Biankin, Andrew V, et al.
Publicado: (2013) -
We refuse to die – T cells causing havoc
por: Kattner, Aila Akosua
Publicado: (2021) -
Hypermutation takes the driver’s seat
por: Schlesner, Matthias, et al.
Publicado: (2015)